Drug Trial Radar · NCT00947960
Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease
Last checked: Nov 20, 2026Latest source record: Mar 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Jun 2009
Primary completion
Jul 2015
Study completion Jul 2015
Sponsor
- Lead sponsor
- Baylor Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Ultragenyx Pharmaceutical Inc
- First posted
- Jul 28, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine if triheptanoin is an effective treatment for the symptoms of Adult Polyglucosan Body Disease.
Conditions
- Adult Polyglucosan Body Disease
- Glycogen Brancher Enzyme Deficiency
- Glycogen Storage Disease Type IV
Interventions
TriheptanoinDrug
1-2 grams triheptanoin (drug)/kilogram body weight divided into 4 equal doses per day taken with meals and a snack for 6 months followed by 1-2 grams vegetable oil (placebo)/kilogram body weight divided into 4 equal doses per day taken with meals and a snack for 6 months.
Vegetable OilOther
1-2 grams vegetable oil (placebo)/kilogram body weight divided into 4 equal doses per day taken with meals and a snack for 6 months followed by 1-2 g triheptanoin (drug)/kilogram body weight for 6 months.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Distance traveled in six minute walk testTime frame: every three months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière
Paris, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.